Bank Of New York Mellon Corp Dice Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$26.05 - $32.31 $3.42 Million - $4.25 Million	131,384 New	131,384 $3.76 Billion
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $2.71 Million - $5.78 Million	136,982 New	136,982 $4.27 Million
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $351,091 - $531,210	23,453 Added 32.84%	94,864 $1.92 Million
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $433,634 - $726,559	32,876 Added 85.31%	71,411 $1.11 Million
Q1 2022 May 11, 2022	BUY	$14.54 - $25.02 $75,491 - $129,903	5,192 Added 15.57%	38,535 $737,000
Q4 2021 Feb 11, 2022	BUY	$22.41 - $37.54 $747,216 - $1.25 Million	33,343 New	33,343 $844,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.